Search

Your search keyword '"Gilabert, M."' showing total 475 results

Search Constraints

Start Over You searched for: Author "Gilabert, M." Remove constraint Author: "Gilabert, M."
475 results on '"Gilabert, M."'

Search Results

2. A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma

7. Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein

8. Association between new-onset right bundle branch block and primary or secondary ventricular fibrillation in ST-segment elevation myocardial infarction

16. A feasibility study for 3 strategies promoting HIV testing in primary health care in Madrid, Spain (ESTVIH project)

19. A Tool for Activity Estimation in FPGAs

21. Sesqui- and triterpenoids from the liverwort Lepidozia chordulifera inhibitors of bacterial biofilm and elastase activity of human pathogenic bacteria

25. Myotonic dystrophy type 1 drug development: A pipeline toward the market

29. A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma

30. Evaluation of the LSA-SAF gross primary production product derived from SEVIRI/MSG data (MGPP)

31. A Molecular Gradient as a universal classifier of pancreatic adenocarcinoma that predicts tumor aggressiveness and mFOLFIRINOX sensitivity.

32. Identification of deregulated glycosyltransferase genes to detect poor pronostic groups of pancreatic ducal adenocarcinoma patients

35. Exploring Ecosystem Functioning in Spain with Gross and Net Primary Production Time Series.

39. PD-6 Gemcitabine + nab-paclitaxel or gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: A population-based, multicenter AGEO study

41. Impact of fiducial markers placements on the delineation of target volumes in radiation therapy for oesophageal cancer: final results of the FIDUCOR study

44. Stereospecificity of horseradish peroxidase

46. Regorafenib combined with irinotecan as second-line treatment in patients with metastatic gastro-oesophageal adenocarcinomas: A randomized phase 2 trial (PRODIGE 58 – UCGI 35 – REGIRI)

Catalog

Books, media, physical & digital resources